Q (sonnet): What is the correlation coefficient between EGFR copy number and EGFR mRNA expression in ovarian cancer? ▶ read_guide { "uri": "cbioportal://gene-expression-guide" } ▶ list_studies { "search": "ovarian TCGA" } ◀ result # Gene Expression Analysis Guide This guide covers continuous-value genomic data: gene **expression**, **copy number** values, **methylation**, and related profile types. Mutation/CNA/SV *frequency* analysis lives in `cbioportal://mutation-frequency-guide`. ## Where this data lives Continuous per-sample-per-gene values are stored in `genetic_alteration_derived`: | Column | Description | |---|---| | `sample_unique_id` | `_` | | `cancer_study_identifier` | study scope | | `hugo_gene_symbol` | gene | | `profile_type` | which assay/normalization (see below) | | `alteration_value` | the actual value — stored as Nullable(String); cast with `toFloat64OrNull` | `alteration_value` is a string because the same column hosts many different value scales. The `''` and `'NA'` sentinels mean "missing"; always filter them out and use `toFloat64OrNull(alteration_value) IS NOT NULL` for downstream math. ## Discovering profile types for a study Different studies expose different profile types depending on what assays were run and how the data was normalized. Always check what a specific study supports before picking one: ```sql SELECT DISTINCT profile_type FROM genetic_alteration_derived WHERE cancer_study_identifier = 'brca_metabric' ORDER BY profile_type; ``` Common values across the public portal: | Family | Profile types | |---|---| | mRNA expression | `mrna`, `mrna_median_Zscores`, `mrna_seq_v2_rsem`, `mrna_seq_v2_rsem_Zscores`, `mrna_seq_cpm`, `mrna_seq_fpkm`, `mrna_U133`, `mrna_outliers` | | Copy number (continuous) | `cna`, `linear_CNA`, `log2CNA`, `cna_consensus`, `cna_rae`, `gistic` | | Methylation | `methylation_hm27`, `methylation_hm450`, `methylation_epic`, `methylation_promoters_rrbs` | | miRNA | `mirna`, `mirna_median_Zscores` | | Protein | `protein_quantification`, `protein_level`, `RPPA` | **Z-score vs raw choice.** When the user asks "is X correlated with Y", either works for Spearman (rank-based) — Pearson would care. Default to the non-Z-score variant if both exist, and call out which one in the response. ## Canonical recipe — Spearman correlation between two genes ```sql SELECT * FROM gene_pair_coexpression( study = 'brca_metabric', gene_a = 'TP53', gene_b = 'MYC', profile_type = 'mrna' ); ``` Returns one row: `(gene_a, gene_b, profile_type, spearman_correlation, num_samples)`. - `spearman_correlation` in [−1, 1]; `NULL` when fewer than 3 valid paired samples. - Mirrors cbioportal-backend's `ClickhouseCoExpressionMapper.getCoExpressions`, simplified to a pair lookup (the backend computes one ref gene vs ALL other genes for the coexpression page; here the agent asks about a specific pair). ### Verified examples | Study | gene_a | gene_b | profile_type | spearman | n | |---|---|---|---|---|---| | `brca_metabric` | TP53 | MYC | `mrna` | 0.118 | 1980 | | `brca_metabric` | ESR1 | PGR | `mrna` | 0.487 | 1980 | ESR1↔PGR is the textbook breast-cancer estrogen-receptor coregula … (2785 more chars) ◀ result {"result":[{"cancer_study_identifier":"ov_tcga","name":"Ovarian Serous Cystadenocarcinoma (TCGA, Firehose Legacy)","type_of_cancer_id":"hgsoc","sample_count":617,"has_guide":false,"url":"https://www.cbioportal.org/study/summary?id=ov_tcga"},{"cancer_study_identifier":"hgsoc_tcga_gdc","name":"High-Grade Serous Ovarian Cancer (TCGA GDC, 2025)","type_of_cancer_id":"hgsoc","sample_count":604,"has_guide":false,"url":"https://www.cbioportal.org/study/summary?id=hgsoc_tcga_gdc"},{"cancer_study_identifier":"ov_tcga_pan_can_atlas_2018","name":"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)","type_of_cancer_id":"hgsoc","sample_count":585,"has_guide":true,"url":"https://www.cbioportal.org/study/summary?id=ov_tcga_pan_can_atlas_2018"},{"cancer_study_identifier":"ov_tcga_pub","name":"Ovarian Serous Cystadenocarcinoma (TCGA, Nature 2011)","type_of_cancer_id":"hgsoc","sample_count":489,"has_guide":false,"url":"https://www.cbioportal.org/study/summary?id=ov_tcga_pub"},{"cancer_study_identifier":"mixed_msk_tcga_2021","name":"RAD51B Associated Mixed Cancers (MSK, NPJ Breast Cancer 2021)","type_of_cancer_id":"mixed","sample_count":17,"has_guide":false,"url":"https://www.cbioportal.org/study/summary?id=mixed_msk_tcga_2021"}]} ▶ clickhouse_run_select_query { "query": "SELECT DISTINCT profile_type FROM genetic_alteration_derived WHERE cancer_study_identifier = 'ov_tcga_pan_can_atlas_2018' ORDER BY profile_type" } ◀ result {"rows":[{"profile_type":"gistic"},{"profile_type":"log2CNA"},{"profile_type":"protein_quantification"},{"profile_type":"protein_quantification_zscores"},{"profile_type":"rna_seq_v2_mrna"},{"profile_type":"rna_seq_v2_mrna_median_Zscores"},{"profile_type":"rna_seq_v2_mrna_median_all_sample_Zscores"},{"profile_type":"rppa"},{"profile_type":"rppa_Zscores"}]} ▶ clickhouse_run_select_query { "query": "WITH a AS ( SELECT sample_unique_id, toFloat64OrNull(alteration_value) AS v FROM genetic_alteration_derived WHERE cancer_study_identifier = 'ov_tcga_pan_can_atlas_2018' AND profile_type = 'log2CNA' AND hugo_gene_symbol = 'EGFR' AND alteration_value NOT IN ('', 'NA') AND toFloat64OrNull(alteration_value) IS NOT NULL ), b AS ( SELECT sample_unique_id, toFloat64OrNull(alteration_value) AS v FROM genetic_alteration_derived WHERE cancer_study_identifier = 'ov_tcga_pan_can_atlas_2018' AND profile_type = 'rna_seq_v2_mrna' AND hugo_gene_symbol = 'EGFR' AND alteration_value NOT IN ('', 'NA') AND toFloat64OrNull(alteration_value) IS NOT NULL ) SELECT rankCorr(a.v, b.v) AS spearman_correlation, corr(a.v, b.v) AS pearson_correlation, count() AS num_samples FROM a INNER JOIN b USING (sample_unique_id)" } ◀ result {"rows":[{"spearman_correlation":0.36354541587592437,"pearson_correlation":0.3354486827217539,"num_samples":295}]} ▶ resolve_and_route { "studyIds": [ "ov_tcga_pan_can_atlas_2018" ] } ◀ result {"success":true,"message":"Found 1 study. Use the metadata to call the appropriate navigation tool(s).","data":{"totalCount":1,"studiesWithMetadata":[{"studyId":"ov_tcga_pan_can_atlas_2018","name":"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)","sampleCount":585,"studyViewUrl":"https://www.cbioportal.org/study?id=ov_tcga_pan_can_atlas_2018","metadata":{"clinicalAttributeIds":["AGE","AJCC_PATHOLOGIC_TUMOR_STAGE","AJCC_STAGING_EDITION","ANEUPLOIDY_SCORE","BUFFA_HYPOXIA_SCORE","CANCER_TYPE","CANCER_TYPE_ACRONYM","CANCER_TYPE_DETAILED","DAYS_LAST_FOLLOWUP","DAYS_TO_BIRTH","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","DFS_MONTHS","DFS_STATUS","DSS_MONTHS","DSS_STATUS","ETHNICITY","FORM_COMPLETION_DATE","FRACTION_GENOME_ALTERED","GENETIC_ANCESTRY_LABEL","GRADE","HISTORY_NEOADJUVANT_TRTYN","ICD_10","ICD_O_3_HISTOLOGY","ICD_O_3_SITE","INFORMED_CONSENT_VERIFIED","IN_PANCANPATHWAYS_FREEZE","MSI_SCORE_MANTIS","MSI_SENSOR_SCORE","MUTATION_COUNT","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","ONCOTREE_CODE","OS_MONTHS","OS_STATUS","OTHER_PATIENT_ID","PATH_M_STAGE","PATH_N_STAGE","PATH_T_STAGE","PERSON_NEOPLASM_CANCER_STATUS","PFS_MONTHS","PFS_STATUS","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","PRIOR_DX","RACE","RADIATION_THERAPY","RAGNUM_HYPOXIA_SCORE","SAMPLE_COUNT","SAMPLE_TYPE","SEX","SOMATIC_STATUS","SUBTYPE","TBL_SCORE","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","TISSUE_SOURCE_SITE","TISSUE_SOURCE_SITE_CODE","TMB_NONSYNONYMOUS","TUMOR_TISSUE_SITE","TUMOR_TYPE","WEIGHT","WINTER_HYPOXIA_SCORE"],"molecularProfileIds":["ov_tcga_pan_can_atlas_2018_gistic","ov_tcga_pan_can_atlas_2018_log2CNA","ov_tcga_pan_can_atlas_2018_mutations","ov_tcga_pan_can_atlas_2018_protein_quantification","ov_tcga_pan_can_atlas_2018_protein_quantification_zscores","ov_tcga_pan_can_atlas_2018_rna_seq_v2_mrna","ov_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","ov_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_all_sample_Zscores","ov_tcga_pan_can_atlas_2018_rppa","ov_tcga_pan_can_atlas_2018_rppa_Zscores","ov_tcga_pan_can_atlas_2018_structural_variants"],"genericAssayProfiles":["ov_tcga_pan_can_atlas_2018_armlevel_cna","ov_tcga_pan_can_atlas_2018_genetic_ancestry","ov_tcga_pan_can_atlas_2018_methylation_hm27_hm450_merge","ov_tcga_pan_can_atlas_2018_methylation_hm450","ov_tcga_pan_can_atlas_2018_phosphoprotein_quantification"],"heatmapProfileIds":["ov_tcga_pan_can_atlas_2018_protein_quantification_zscores","ov_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_Zscores","ov_tcga_pan_can_atlas_2018_rna_seq_v2_mrna_median_all_sample_Zscores","ov_tcga_pan_can_atlas_2018_rppa_Zscores"],"availableComparisonTabs":["overlap","clinical","survival","alterations","mutations","mrna","protein","generic_assay_armlevel_cna","generic_assay_genetic_ancestry","generic_assay_methylation","generic_assay_phosphosite_quantification"]}}]}} ▶ navigate_to_results_view { "studyIds": [ "ov_tcga_pan_can_atlas_2018" ], "genes": [ "EGFR" ], "tab": "plots", "plotsHorzSelection": { "dataType": "copy_number", "selectedGeneOption": "EGFR", "selectedDataSourceOption": "log2CNA" }, "plotsVertSelection": { "dataType": "mrna", "selectedGeneOption": "EGFR", "selectedDataSourceOption": "rna_seq_v2_mrna" } } ◀ result {"success":true,"message":"Navigating to https://www.cbioportal.org/results/plots?cancer_study_list=ov_tcga_pan_can_atlas_2018&gene_list=EGFR&case_set_id=ov_tcga_pan_can_atlas_2018_all&plots_horz_selection=%7B%22selectedGeneOption%22%3A%221956%22%2C%22dataType%22%3A%22copy_number%22%2C%22selectedDataSourceOption%22%3A%22log2CNA%22%7D&plots_vert_selection=%7B%22selectedGeneOption%22%3A%221956%22%2C%22dataType%22%3A%22mrna%22%2C%22selectedDataSourceOption%22%3A%22rna_seq_v2_mrna%22%7D","url":"https://www.cbioportal.org/results/plots?cancer_study_list=ov_tcga_pan_can_atlas_2018&gene_list=EGFR&case_set_id=ov_tcga_pan_can_atlas_2018_all&plots_horz_selection=%7B%22selectedGeneOption%22%3A%221956%22%2C%22dataType%22%3A%22copy_number%22%2C%22selectedDataSourceOption%22%3A%22log2CNA%22%7D&plots_vert_selection=%7B%22selectedGeneOption%22%3A%221956%22%2C%22dataType%22%3A%22mrna%22%2C%22selectedDataSourceOption%22%3A%22rna_seq_v2_mrna%22%7D","data":{"studyIds":["ov_tcga_pan_can_atlas_2018"],"studies":[{"studyId":"ov_tcga_pan_can_atlas_2018","name":"Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)","sampleCount":585}],"genes":["EGFR"],"caseSetId":"ov_tcga_pan_can_atlas_2018_all","pageDescription":"Scatter/box plots: EGFR mrna (y-axis) by EGFR copy_number (x-axis)."}} ═ answer (success) ## EGFR Copy Number vs. mRNA Expression — Ovarian Cancer **Cohort:** Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas) — 295 samples with paired continuous copy-number (log2CNA) and mRNA (RNA-Seq V2 RSEM) data for EGFR, out of 585 total samples in the study. | Metric | Value | |---|---| | Spearman correlation (ρ) | **0.364** | | Pearson correlation (r) | 0.335 | | Paired samples (n) | 295 | This is a **moderate positive correlation**: samples with higher EGFR copy number tend to have higher EGFR mRNA expression, consistent with a partial gene-dosage effect, though copy number alone explains only a modest fraction of expression variance (r² ≈ 0.11–0.13). You can explore the scatter plot directly (each point is one tumor sample, EGFR mRNA on the y-axis vs. EGFR copy number on the x-axis): [EGFR Copy Number vs. mRNA Expression — Plots Tab](https://www.cbioportal.org/results/plots?cancer_study_list=ov_tcga_pan_can_atlas_2018&gene_list=EGFR&case_set_id=ov_tcga_pan_can_atlas_2018_all&plots_horz_selection=%7B%22selectedGeneOption%22%3A%221956%22%2C%22dataType%22%3A%22copy_number%22%2C%22selectedDataSourceOption%22%3A%22log2CNA%22%7D&plots_vert_selection=%7B%22selectedGeneOption%22%3A%221956%22%2C%22dataType%22%3A%22mrna%22%2C%22selectedDataSourceOption%22%3A%22rna_seq_v2_mrna%22%7D) The Plots tab will also display its own correlation statistics computed live on the current sample selection, which you can use to cross-check the values above.